Data

Invasive group A Streptococcus disease in Australian children: 2016 to 2018 – a descriptive cohort study

The University of Western Australia
Oliver, Jane ; Thielemans, Elise ; McMinn, Alissa ; Baker, Ciara ; Britton, Philip N. ; Clark, Julia E. ; Marshall, Helen S. ; Blyth, Christopher C. ; Francis, Joshua ; Buttery, Jim ; Steer, Andrew C. ; Crawford, Nigel W.
Viewed: [[ro.stat.viewed]] Cited: [[ro.stat.cited]] Accessed: [[ro.stat.accessed]]
ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rfr_id=info%3Asid%2FANDS&rft_id=info:doi10.6084/m9.figshare.c.4801455&rft.title=Invasive group A Streptococcus disease in Australian children: 2016 to 2018 – a descriptive cohort study&rft.identifier=10.6084/m9.figshare.c.4801455&rft.publisher=Figshare&rft.description=Abstract Objectives Invasive group A Streptococcus (iGAS) disease is serious and sometimes life-threatening. The Paediatric Active Enhanced Disease Surveillance (PAEDS) Network collects voluntary notifications from seven major Australian paediatric hospitals on patients with certain conditions, including iGAS disease. Our aims were to: 1) Describe the epidemiological distribution of paediatric iGAS disease in Australia and correlate this with influenza notifications, 2) Identify GAS strains commonly associated with invasive disease in children. Methods IGAS and influenza notification data were obtained (from the PAEDS Network and the Australian Institute of Health and Welfare, respectively, for the period 1 July 2016 to 30 June 2018). Included iGAS patients had GAS isolated from a normally sterile body site. Data were described according to selected clinical and demographic characteristics, including by age group and Australian State, with proportions and minimum incidence rates estimated. Results A total of 181 patients were identified, with most (115, 63.5%) &rft.creator=Oliver, Jane &rft.creator=Thielemans, Elise &rft.creator=McMinn, Alissa &rft.creator=Baker, Ciara &rft.creator=Britton, Philip N. &rft.creator=Clark, Julia E. &rft.creator=Marshall, Helen S. &rft.creator=Blyth, Christopher C. &rft.creator=Francis, Joshua &rft.creator=Buttery, Jim &rft.creator=Steer, Andrew C. &rft.creator=Crawford, Nigel W. &rft.date=2021&rft.relation=http://research-repository.uwa.edu.au/en/publications/5b36e19c-2765-4d1d-b2b7-0a4a7f4d7974&rft.type=dataset&rft.language=English Access the data

Access:

Open

Full description

Abstract Objectives Invasive group A Streptococcus (iGAS) disease is serious and sometimes life-threatening. The Paediatric Active Enhanced Disease Surveillance (PAEDS) Network collects voluntary notifications from seven major Australian paediatric hospitals on patients with certain conditions, including iGAS disease. Our aims were to: 1) Describe the epidemiological distribution of paediatric iGAS disease in Australia and correlate this with influenza notifications, 2) Identify GAS strains commonly associated with invasive disease in children. Methods IGAS and influenza notification data were obtained (from the PAEDS Network and the Australian Institute of Health and Welfare, respectively, for the period 1 July 2016 to 30 June 2018). Included iGAS patients had GAS isolated from a normally sterile body site. Data were described according to selected clinical and demographic characteristics, including by age group and Australian State, with proportions and minimum incidence rates estimated. Results A total of 181 patients were identified, with most (115, 63.5%) <5 years old. The mean annual minimum incidence rate was 1.6 (95% confidence interval: 1.1–2.3) per 100,000 children across the study period. An epidemiological correlation with the seasonal burden of influenza was noted. Contact prophylaxis was not consistently offered. Of 96 patients with emm-typing results available, 72.9% showed emm-1, −4 or − 12. Conclusions Robust surveillance systems and cohesive patient management guidelines are needed. Making iGAS disease nationally notifiable would help facilitate this. Influenza vaccination may contribute to reducing seasonal increases in iGAS incidence. The burden of disease emphasises the need for ongoing progress in GAS vaccine development.

Notes

External Organisations
University of Brussels; Murdoch Children's Research Institute; Children's Hospital at Westmead; University of Queensland; Women's and Children's Hospital Adelaide; Menzies School of Health Research
Associated Persons
Elise Thielemans (Creator); Alissa McMinn (Creator); Ciara Baker (Creator); Philip N. Britton (Creator); Julia E. Clark (Creator); Helen S. Marshall (Creator); Joshua Francis (Creator); Jim Buttery (Creator); Andrew C. Steer (Creator); Nigel W. Crawford (Creator)

Issued: 2021

This dataset is part of a larger collection

Click to explore relationships graph

User Contributed Tags    

Login to tag this record with meaningful keywords to make it easier to discover

Identifiers